Our results suggested that CHFR was not only acted as a tumor suppressor by inhibiting cell cycle progression, but also promoted the cell migration and invasion by activating AKT and ERK in a NRF2-ROS axis. The gene discussed is NFE2L2; the disease is neoplasm.